Cross-Tracer Synthesis Model of <sup>11</sup>C-CFT and <sup>18</sup>F-DOPA PET Images from <sup>18</sup>F-FDG for Parkinson's Disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42268758.
- Also identified by DOI 10.1109/JBHI.2026.3702259.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Positron emission tomography (PET) with various tracers plays a critical role in Parkinson's disease (PD) studies. However, the clinical application of PET with novel or less-available tracers is limited by factors such as high cost and short half-life. To address this limitation, we developed a cross-tracer PET synthesis model based on diffusion model to directly synthesize cross-tracer PET images from widely used <sup>18</sup>F-FDG PET images for PD studies. The network was initially trained on <sup>18</sup>F-FDG and <sup>11</sup>C-CFT datasets, and subsequently fine-tuned on <sup>18</sup>F-FDG and <sup>18</sup>F-DOPA datasets. After anonymization, synthetic images were mixed with real ones and underwent visual assessment by radiologists. Quantitative analyses were further performed through voxel-wise comparisons and regional error analysis between synthetic and real images. Visual assessment indicated that the synthetic <sup>11</sup>C-CFT and <sup>18</sup>F-DOPA PET images were comparable to real images in terms of quality, noise, and striatal conspicuity, with no significant differences observed in the error maps. Synthetic <sup>11</sup>C-CFT images achieved an average PSNR of 36.22 and an SSIM of 0.96, whereas <sup>18</sup>F-DOPA images yielded values of 29.79 and 0.95, respectively. Bland-Altman analysis indicated high consistency between synthetic and real images. The average standardized uptake value (SUV) bias was 0.013 $\pm$ 0.032 SUV for <sup>11</sup>C-CFT and -0.175 $\pm$ 0.149 SUV for <sup>18</sup>F-DOPA. The proposed cross-tracer PET synthesis model achieves comparable performance with <sup>11</sup>C-CFT or <sup>18</sup>F-DOPA PET imaging for PD studies.